← Back to Clinical Trials
Recruiting NCT07219498

NCT07219498 Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07219498
Status Recruiting
Phase
Sponsor University of Minnesota
Condition Exercise Induced Muscle Damage
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2026-02-05
Primary Completion 2026-04-30

Trial Parameters

Condition Exercise Induced Muscle Damage
Sponsor University of Minnesota
Study Type INTERVENTIONAL
Phase N/A
Enrollment 24
Sex ALL
Min Age 18 Years
Max Age 30 Years
Start Date 2026-02-05
Completion 2026-04-30
Interventions
Lactobacillus caseiPlacebo Capsule(s)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to evaluate how probiotic supplementation (PS) influences post-exercise recovery in healthy, physically active young adults. Researchers aim to determine if the Lactobacillus casei probiotic strain reduces symptoms of delayed onset muscle soreness (DOMS) based on perceived muscle soreness, pressure pain threshold, and power output following exercise induced muscle damage (EIMD).

Eligibility Criteria

Inclusion Criteria: * complete a minimum of 150 minutes a week of at least moderate intensity exercise in either an endurance-based or resistance-based training style based on a self-reported physical activity over the past month * good general health with no injuries or health conditions that would affect physical activity * willing to abstain from consistent NSAID use and other probiotic supplements over the course of this study Exclusion Criteria: * known musculoskeletal injuries or physical limitations that could interfere with performing the designated physical activity required * underlying conditions that could place them at an increased risk during exercise such as cardiovascular, respiratory, or metabolic diseases * currently take a probiotic supplement, are prescribed and taking an antibiotic during the intervention, or report using NSAIDs or steroids within the recovery time window * report using an NSAID more than twice a week on a regular basis

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology